share_log
Benzinga ·  May 2 07:34
Context Therapeutics Shares Are Trading Higher After the Company Announced FDA Clearance of Its IND Application for a Phase 1 Clinical Trial of CTIM-76
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment